INTERNATIONAL PATENT: DAESANG CORPORATION, 대상 주식회사 FILES APPLICATION FOR "MUTANT MICROORGANISM WITH ENHANCED ABILITY TO PRODUCE NICOTINAMIDE MONONUCLEOTIDE AND METHOD FOR PRODUCING NICOTINAMIDE MONONUCLEOTIDE USING SAME"

GENEVA, July 9 -- DAESANG CORPORATION (26, Cheonho-daeroDongdaemun-guSeoul 02586), 대상 주식회사 (서울특별시동대문구천호대로 26) filed a patent application (PCT/KR2024/021098) for "MUTANT MICROORGANISM WITH ENHANCED ABILITY TO PRODUCE NICOTINAMIDE MONONUCLEOTIDE AND METHOD FOR PRODUCING NICOTINAMIDE MONONUCLEOTIDE USING SAME" on Dec 26, 2024. With publication no. WO/2025/143782, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO...